150 related articles for article (PubMed ID: 27606705)
1. Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.
Zadravec P; Marečková L; Petroková H; Hodnik V; Perišić Nanut M; Anderluh G; Štrukelj B; Malý P; Berlec A
PLoS One; 2016; 11(9):e0162625. PubMed ID: 27606705
[TBL] [Abstract][Full Text] [Related]
2. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
Selyunin AS; Mukhopadhyay S
Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
[TBL] [Abstract][Full Text] [Related]
3. p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.
Škrlec K; Zadravec P; Hlavničková M; Kuchař M; Vaňková L; Petroková H; Křížová L; Černý J; Berlec A; Malý P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29966384
[TBL] [Abstract][Full Text] [Related]
4. Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.
Zadravec P; Štrukelj B; Berlec A
Appl Environ Microbiol; 2015 Mar; 81(6):2098-106. PubMed ID: 25576617
[TBL] [Abstract][Full Text] [Related]
5. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
6. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
7. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
8. Lectin-Mediated Binding of Engineered
Plavec TV; Zahirović A; Zadravec P; Sabotič J; Berlec A
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33499141
[TBL] [Abstract][Full Text] [Related]
9. Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit.
Willysson A; Ståhl AL; Gillet D; Barbier J; Cintrat JC; Chambon V; Billet A; Johannes L; Karpman D
Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32664382
[TBL] [Abstract][Full Text] [Related]
10. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
[TBL] [Abstract][Full Text] [Related]
11. Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.
Zahirović A; Berlec A
Microb Cell Fact; 2022 Jul; 21(1):143. PubMed ID: 35842694
[TBL] [Abstract][Full Text] [Related]
12. Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application.
Miyashita S; Matsuura Y; Miyamoto D; Suzuki Y; Imai Y
Glycoconj J; 1999 Nov; 16(11):697-705. PubMed ID: 11003554
[TBL] [Abstract][Full Text] [Related]
13. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
[TBL] [Abstract][Full Text] [Related]
14. Charged and hydrophobic surfaces on the a chain of shiga-like toxin 1 recognize the C-terminal domain of ribosomal stalk proteins.
McCluskey AJ; Bolewska-Pedyczak E; Jarvik N; Chen G; Sidhu SS; Gariépy J
PLoS One; 2012; 7(2):e31191. PubMed ID: 22355345
[TBL] [Abstract][Full Text] [Related]
15. N-terminus leader sequence of Shiga toxin (Stx) 1 is essential for production of active recombinant protein in E. coli.
Oloomi M; Bouzari S; Arshadi M
Protein Pept Lett; 2006; 13(5):509-12. PubMed ID: 16800807
[TBL] [Abstract][Full Text] [Related]
16. Prokaryotic expression of Stx1B subunit of Escherichia coli O157:H7 used to generate monoclonal antibody.
Li G; Hong J; Ren X; Yin J; Feng S; Huo G
Hybridoma (Larchmt); 2010 Aug; 29(4):283-9. PubMed ID: 20715986
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of the pH sensitive binding of multivalent carbohydrate ligands to immobilized Shiga-like toxin 1 B subunits.
Imai Y; Matsuura Y; Ono Y; Ishikawa T; Ito Y
J Biochem; 2001 Nov; 130(5):665-70. PubMed ID: 11686929
[TBL] [Abstract][Full Text] [Related]
18. Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities.
Škrlec K; Ručman R; Jarc E; Sikirić P; Švajger U; Petan T; Perišić Nanut M; Štrukelj B; Berlec A
Appl Microbiol Biotechnol; 2018 Dec; 102(23):10103-10117. PubMed ID: 30191288
[TBL] [Abstract][Full Text] [Related]
19. System using tandem repeats of the cA peptidoglycan-binding domain from Lactococcus lactis for display of both N- and C-terminal fusions on cell surfaces of lactic acid bacteria.
Okano K; Zhang Q; Kimura S; Narita J; Tanaka T; Fukuda H; Kondo A
Appl Environ Microbiol; 2008 Feb; 74(4):1117-23. PubMed ID: 18156338
[TBL] [Abstract][Full Text] [Related]
20. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2.
Flagler MJ; Mahajan SS; Kulkarni AA; Iyer SS; Weiss AA
Biochemistry; 2010 Mar; 49(8):1649-57. PubMed ID: 20092352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
